Scientists at the Shirley Ryan AbiilityLab in Chicago are studying whether an investigational drug can help the 300,000 Americans living with spinal cord injuries. “We are testing an investigational drug and the potential effect of this medication on functional restoration in people with spinal cord injury,” said Dr. Monica Perez, a scientist and the lead investigator of the clinical trial underway at Shirley Ryan AbilityLab. Called NVG-291, the drug targets the body’s ability to improve nerve connections disrupted by spinal cord injury. “It aims to target the body’s natural capacity to repair. It aims to enhance connections from the brain to different muscles,” Perez said. Rese
Hence then, the article about study determining whether investigational drug can aid those with spinal cord injuries underway was published today ( ) and is available onNBC Chicago ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Study determining whether investigational drug can aid those with spinal cord injuries underway )